- Home
- ARWR vs VC Comparison
ARWR vs VC Comparison
Compare ARWR & VC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ARWR | VC |
|---|---|---|
| Founded | 2003 | 2000 |
| Country | United States | United States |
| Employees | N/A | 10000 |
| Industry | Biotechnology: Pharmaceutical Preparations | Auto Parts:O.E.M. |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.4B | 2.7B |
| IPO Year | 2009 | 2000 |
Fundamental Metrics
Financial Performance| Metric | ARWR | VC |
|---|---|---|
| Price | $67.66 | $98.93 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 10 | 13 |
| Target Price | $83.40 | ★ $125.50 |
| AVG Volume (30 Days) | ★ 1.3M | 337.5K |
| Earning Date | 05-07-2026 | 04-23-2026 |
| Dividend Yield | N/A | ★ 1.39% |
| EPS Growth | ★ 99.80 | N/A |
| EPS | N/A | ★ 2.93 |
| Revenue | $16,142,321.00 | ★ $3,768,000,000.00 |
| Revenue This Year | N/A | $2.39 |
| Revenue Next Year | N/A | $5.21 |
| P/E Ratio | ★ N/A | $33.33 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $28.48 | $83.49 |
| 52 Week High | $95.49 | $128.15 |
Technical Indicators
Market Signals| Indicator | ARWR | VC |
|---|---|---|
| Relative Strength Index (RSI) | 24.99 | 34.86 |
| Support Level | $70.03 | $94.40 |
| Resistance Level | $71.83 | $98.00 |
| Average True Range (ATR) | 3.85 | 2.40 |
| MACD | -1.39 | -0.29 |
| Stochastic Oscillator | 0.03 | 8.25 |
Price Performance
Historical ComparisonAbout ARWR Arrowhead Pharmaceuticals Inc.
Arrowhead Pharmaceuticals Inc is a commercial-stage pharmaceutical company. It is focused on the development of medicines for diseases associated with genetic abnormalities or protein overproduction. The company develops potential RNAi therapies designed to inhibit the expression of genes known to trigger diseases. Its portfolio includes potential drugs targeting Cardiometabolic, Neuromuscular, Pulmonary, Liver, and other diseases. The company also develops RNAi products and clinical candidates designed to target different cell types within the body.
About VC Visteon Corporation
Visteon Corp is an automotive supplier. It manufactures electronics products for original equipment vehicle manufacturers including Ford, Nissan, Renault, Mazda, BMW, General Motors, and Honda, etc. The company offers information displays, instrument clusters, head-up displays, infotainment systems, telematics solutions, and Smartcore. The company's reportable segment is Electronics. The Electronics segment provides vehicle cockpit electronics products to customers, including digital instrument clusters, domain controllers with integrated driver assistance systems, displays, Android-based infotainment systems, and battery management systems. Geographically, it operates in North America, Europe, China, Asia-Pacific, and South America.